Trending Now
ADMA Biologics Inc. (NASDAQ:ADMA) Announces Revenue Of $10.3 Million Q3 2020...
ADMA Biologics Inc. (NASDAQ:ADMA) has reported its Q3 financial results and total revenue of $28.3 million for the nine months ended September 2020. The...
DIH Holding US, Inc. (DHAI): Pioneering Rehabilitation with Cutting-Edge Technology
Let’s talk about something truly inspiring: the future of rehabilitation. On December 23, 2024, DIH Holding US, Inc. (NASDAQ: DHAI) announced...
Predictive Oncology Inc. (Nasdaq: POAI): A Transformative Acquisition by Renovaro Inc.
The biotechnological domain is currently abuzz with developments surrounding the acquisition of Predictive Oncology Inc. (Nasdaq: POAI) by Renovaro Inc. (Nasdaq: RENB)....
Popular News
Royalty Pharma Plc (NASDAQ:RPRX) Shares Surge Over 60% Following Successful IPO
Royalty Pharma Plc (NASDAQ:RPRX) shares surged 59% after it made its trading debut following an upsized IPO, which braised $2.18 billion with top of...
MAKE IT MODERN
LATEST REVIEWS
Green Tech Stocks are Back in Favor (CLSK, ECOX, FCEL, CLNE,...
Looking ahead over the next five years seems like an eternity for postulating portfolio management strategies when it comes to sector allocation....
MAKE IT MODERN
PERFORMANCE TRAINING
Synthetic Biologics Inc. (NYSEAMERICAN: SYN) commences Recruitment and Doses Eight Patients in Phase 1...
Synthetic Biologics Inc. (NYSEAMERICAN: SYN) has commenced enrolment and dosing of eight trial participants in the Phase 1 multiple-ascending dose (MAD), placebo-controlled clinical study...
Clovis Oncology Inc (NASDAQ:CLVS) And Alkermes Plc (NASDAQ:ALKS) Announce Positive Pre-clinical Findings From ALKS...
Clovis Oncology Inc (NASDAQ:CLVS) and Alkermes Plc (NASDAQ:ALKS) recently announced that they observed positive pre-clinical results from a study evaluating ALKS 4230 as a...
Creative Medical Technology Holdings Inc (NASDAQ: CELZ) Announces That StemSpine has High Efficacy
Creative Medical Technology Holdings Inc (NASDAQ: CELZ) has announced that its therapy StemSpine has high efficacy. The company developed the drug to treat chronic...
Osmotica Pharmaceuticals plc (NASDAQ: OSMT) Enters a Note Purchase Agreement And Prices $35 Million...
Osmotica Pharmaceuticals plc (NASDAQ: OSMT) has entered a note purchase agreement with Athyrium Capital Management-managed funds for around $100 million senior secured notes.
Financing offers...
The Eco-Friendly Bull Market (BE, ECOX, ECL, NEE)
The drumbeat around renewable energy and “green” stocks is deafening in recent action, with millennials in charge of the market, launching the likes of...
MAKE IT MODERN
